drugset

drugset / Trial / NCT00533650

Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

NCT00533650 ↗

Phase 2 Completed 227 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupDouble-blindTreatment

Summary

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

Timeline

Start: 2000-12
Primary completion: 2002-10
Completion: 2002-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MK0429	Unknown	—	—

Indications